FUJIFILM Holdings America Corporation · 21 hours ago
Intern, Drug Substance Manufacturing (DSM) - Downstream
FUJIFILM Holdings America Corporation is building the future of bioproduction in Holly Springs, North Carolina. The Intern, Drug Substance Manufacturing will support critical manufacturing activities and aid in refining or developing manufacturing business systems needed to operate the site.
Artificial Intelligence (AI)Machine LearningMotion CapturePhotographyPrinting
Responsibilities
Learn the drug substance manufacturing process and understand how it runs through the DSM facility
Execute projects which could include but are not limited to:
Creating knowledge management tools for manufacturing
Developing short training videos on key manufacturing topics
Assist in value stream and business process mapping, and continuous improvement related to these items
Qualification
Required
Currently enrolled in an Associate's Degree program with a Life Sciences focus OR Currently enrolled in an Engineering or Scientific Undergraduate or Master's degree Program
Proficient in Microsoft Word, Excel, and PowerPoint
Preferred
Prior experience in Pharma/Biotech/Chemical Industry
Prior hands-on technical experience (in a laboratory or manufacturing environment)
Company
FUJIFILM Holdings America Corporation
For over 90 years, Fujifilm has found #ValueFromInnovation through expanding its portfolio to represent a broad spectrum of industries including medical and life sciences, electronic, chemical, graphic arts, information systems, industrial products, broadcast, data storage, and photography.
H1B Sponsorship
FUJIFILM Holdings America Corporation has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2022 (2)
Funding
Current Stage
Late StageTotal Funding
unknown2006-06-13Acquired
Company data provided by crunchbase